(1′R,2R,4′S,5S,6R,8′R,10′E,13′R,14′E,16′E,20′S,24′S)-6-Ethyl-24′-hydroxy-5,11′,13′,22′-tetramethyl-3,4,5,6-tetrahydrospiro[pyran-2,6′-[3,7,19 ]trioxa tetracyclo-[15.6.1.14,8.020,24]pentacosa[10,14,16,22]tetraene]-2′,21′-dione ;
Milbemycin EP Impurity E is a fully characterized chemical compound used as a reference standard of API Milbemycin. The standard offered is compliant with regulatory guidelines. Milbemycin EP Impurity E is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 86691-97-6
Related products
Milbemycin Oxime (Mixture of Milbemycin Oxime A3 and A4)
M.F.
M.W. 541.69
CAT# AR-M04690
CAS# 129496-10-2
